Clinical Trial Update: The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study

View source ↗

Summary

A prospective, multicenter observational study in China assessing the real-world effectiveness and safety of glofitamab in adults with relapsed or refractory di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Glofitamab (Lunsumio) (glofitamab)

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B Cell Lymphoma (DLBCL) | Status: NOT_YET_RECRUITING